AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
R21 Malaria Antigen in Kenya
1 product registered with PPB — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| R21 Malaria Vaccine (Recombinant, Adjuvanted) Solution For Injection | H2022/CTD10567/23346 | Serum Institute of India Pvt Limited | active | 10 Dec 2028 |
R21 Malaria Antigen — PPB Registration Details
PPB (Kenya) has 1 registered product containing R21 Malaria Antigen, of which 1 is currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track R21 Malaria Antigen registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.